Fund HoldingsSaturn V Capital Management LP

Total Portfolio Value
$552.22M
Total Bought
$116.15M
Total Sold
$108.40M
Net Transaction
+$7.74M
Filing Period:
Securities
SharesValue ($K)
Q4 2025
Q1 2026
Change
Q4 2025
Q1 2026
Weight (%)
Change
ALUMIS INC3,135,9533,202,075+66,12230,60770,54212.77%+39,935
IMMIX BIOPHARMA INC2,999,1693,693,585+694,41615,68633,6496.09%+17,963
CANDEL THERAPEUTICS INC02,896,588+2,896,588014,1932.57%+14,193
VAXCYTE INC(PCVX)798,940824,532+25,59236,86347,9148.68%+11,050
AMYLYX PHARMACEUTICALS INC(AMLX)4,496,4874,349,885-146,60254,31860,46310.95%+6,146
OVID THERAPEUTICS INC2,500,0004,166,666+1,666,6664,0759,2501.68%+5,175
DISC MEDICINE INC(IRON)298,429449,926+151,49723,69828,7685.21%+5,070
ZURA BIO LTD0739,960+739,96004,4030.80%+4,403
X4 PHARMACEUTICALS INC5,800,5306,456,646+656,11623,20226,6664.83%+3,464
OCULIS HOLDING AG516,761516,761010,32013,7412.49%+3,421
PHARVARIS N V
COM
1,140,0331,201,402+61,36931,63633,9406.15%+2,304
ALTO NEUROSCIENCE INC(ANRO)088,999+88,99902,0010.36%+2,001
SATELLOS BIOSCIENCE INC0350,000+350,00001,9710.36%+1,971
CELCUITY INC(CELC)317,095281,904-35,19131,62732,1775.83%+549
INVENTIVA SA(IVA)283,1660-283,1661,3170-1,317
INHIBIKASE THERAPEUTICS INC3,856,7993,863,445+6,6467,9066,4911.18%-1,416
MONOPAR THERAPEUTICS INC325,701345,626+19,92521,26818,9373.43%-2,331
INVIVYD INC7,735,38610,949,084+3,213,69819,10614,2342.58%-4,873
CENTESSA PHARMACEUTICALS PLC282,6920-282,6927,0700-7,070
JAZZ PHARMACEUTICALS PLC(JAZZ)248,070162,961-85,10942,17230,8085.58%-11,364
DYNE THERAPEUTICS INC(DYN)1,788,616966,609-822,00734,98517,5253.17%-17,461
OCULAR THERAPEUTIX INC(OCUL)1,504,8800-1,504,88018,2690-18,269
COGENT BIOSCIENCES INC(COGT)1,217,064626,635-590,42943,23024,1194.37%-19,111
ABIVAX SA(ABVX)649,179542,696-106,48387,54560,42910.94%-27,116
Page 1 of 1